Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats
- PMID: 20521124
- DOI: 10.1007/s12031-010-9392-3
Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats
Abstract
The retina is constantly exposed to ultraviolet (UV) light with different wavelengths, which may lead to chronic UV-induced retinal injury. In our previous studies, we have shown the protective effects of pituitary adenylate cyclase activating polypeptide (PACAP) in toxic and ischemic retinal injuries. The aim of the present study was to investigate the effects of PACAP in UV-A-induced retinal lesion. We used diffuse UV-A radiation (315-400 nm) to induce acute retinal damage over a short period of exposure. Using standard histological (morphological and morphometrical) analysis, we assessed the actions of intravitreal PACAP (100 pmol/5 µl) treatment on acute UV-A-induced retinal damage. We measured the thickness of nuclear and plexiform layers as well as the number of cells in the outer nuclear and inner nuclear layers and in the ganglion cell layer. Outer limiting membrane-inner limiting membrane distances in the cross-section of the retina were also examined. Our results show that UV-A light-induced retinal damage led to severe degeneration in the photoreceptor layer, and in the outer and inner nuclear layers. Alteration in the plexiform layers was also observed. We found that post-irradiation PACAP treatment significantly attenuated the UV-A-induced retinal damage. Our results provide the basis for future clinical application of PACAP treatment in retinal degeneration and may have clinical implications in several ophthalmic diseases.
Similar articles
-
PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.J Mol Neurosci. 2011 Jan;43(1):44-50. doi: 10.1007/s12031-010-9406-1. Epub 2010 Jun 22. J Mol Neurosci. 2011. PMID: 20567936
-
Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.J Mol Neurosci. 2012 Nov;48(3):501-7. doi: 10.1007/s12031-012-9774-9. Epub 2012 Apr 29. J Mol Neurosci. 2012. PMID: 22544514
-
Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.Neurotox Res. 2005 Nov;8(3-4):227-33. doi: 10.1007/BF03033976. Neurotox Res. 2005. PMID: 16371317
-
Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.Ann N Y Acad Sci. 2010 Jul;1200:128-39. doi: 10.1111/j.1749-6632.2010.05512.x. Ann N Y Acad Sci. 2010. PMID: 20633141 Review.
-
Pleiotropic and retinoprotective functions of PACAP.Anat Sci Int. 2016 Sep;91(4):313-24. doi: 10.1007/s12565-016-0351-0. Epub 2016 Jun 20. Anat Sci Int. 2016. PMID: 27324639 Review.
Cited by
-
Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina.Front Endocrinol (Lausanne). 2012 Nov 23;3:145. doi: 10.3389/fendo.2012.00145. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 23189073 Free PMC article.
-
The Healthy and Diseased Retina Seen through Neuron-Glia Interactions.Int J Mol Sci. 2024 Jan 17;25(2):1120. doi: 10.3390/ijms25021120. Int J Mol Sci. 2024. PMID: 38256192 Free PMC article. Review.
-
Pleiotropic functions of pituitary adenylyl cyclase-activating polypeptide on retinal ontogenesis: involvement of KLF4 in the control of progenitor cell proliferation.J Mol Neurosci. 2014 Nov;54(3):430-42. doi: 10.1007/s12031-014-0299-2. Epub 2014 Apr 9. J Mol Neurosci. 2014. PMID: 24715357
-
PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy.J Mol Neurosci. 2021 Aug;71(8):1525-1535. doi: 10.1007/s12031-020-01769-4. Epub 2021 Jan 5. J Mol Neurosci. 2021. PMID: 33403597 Review.
-
Spatiotemporal Expression Changes of PACAP and Its Receptors in Retinal Ganglion Cells After Optic Nerve Crush.J Mol Neurosci. 2019 Jul;68(3):465-474. doi: 10.1007/s12031-018-1203-2. Epub 2018 Nov 10. J Mol Neurosci. 2019. PMID: 30415445
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources